|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities | |||||
| Stock-based compensation | |||||
| Impairment charge on investment in equity securities | |||||
| Depreciation | |||||
| Loss on disposal of assets | |||||
| Changes in operating assets and liabilities: | |||||
| Prepaid materials | |||||
| Research and development tax rebate receivable | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Payroll liabilities | |||||
| Other current liabilities | |||||
| Net cash used in operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||
| Purchase of investment in equity securities | |||||
| Purchase of property and equipment | |||||
| Net cash used in investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||
| Proceeds from exercise of warrants | |||||
| Common stock repurchased | |||||
| Net cash provided by financing activities | |||||
| NET DECREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH | |||||
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING BALANCE | |||||
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH, ENDING BALANCE | |||||
| Noncash Investing and Financing Items | |||||
| Common stock issued upon cashless exercise of stock options | |||||
| Conversion of Series B convertible preferred stock to common stock | |||||
| RECONCILIATION OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...